kentucky semaglutide intestinal paralysis lawsuit Novo Nordisk, maker of the popular medications Ozempic and Wegovy, filed a Tuesday against the pharmaceutical company Eli Lilly, accusing it of making deceptive advertising claims about its weight-loss drug Zepbound glp-1 gastric stasis legal team

When administered as a once-weekly subcutaneous injection, Ozempic helps to: Stimulate insulin secretion from the pancreas in response to elevated blood glucose levels Suppress glucagon release , reducing the liver's production of glucose Slow gastric emptying , which helps control post-meal blood sugar spikes Reduce appetite , often leading to weight loss as a secondary benefit The mechanism of action centres on the GLP-1 receptor, which is found in various tissues including the pancreas, brain, and gastrointestinal tract

5-HT is a monoamine neurotransmitter and predominantly concentrated in the gastrointestinal tract, platelets and central nervous system [60]

10.1016/j.gendis.2022.02.007 10 AntunesM.BialaG

However, poor response often reflects dose, adherence, diet, or underlying metabolic factors